A description is given of the preparation of N4-di(2-chloro n-propyl) sulphadiazine (pyrimidine I4C-2), specific activity : 16.6 mCi/mM, for cancer research. As intermediate product 2-amino pyrimidine I4C-2 which has not hitherto been described was obtained. Les auteurs dkcrivent la prkparation de
Synthese De La N-acetylmuramyl (OXO-14C-propyl)-L-alanyl-D-isoglutamine (MDP-14C)
✍ Scribed by L. Pichat; J. Tostain; P. Lefrancier; P. Sina; E. Lederer
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- French
- Weight
- 251 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
SYNTHESIS OF N‐ACETYLMURAMYL (^14^C‐OXOPROPYL)‐L‐ALANYL‐D‐ ISOGLUTAMINE (^14^C ‐ MDP)
Condensation of (1‐^14^C) DL‐2‐bromopropionic acid with benzyl 2‐acetamido‐4,6‐0‐benzylidene‐2‐deoxy‐β‐D‐glucopyranoside 7 in presence of sodium hydride gave 50 % of crystalline compound 3, having the correct stereochemistry of natural muramic acid. The latter, in presence of Woodward's reagent, reacted with L‐alanyl‐D‐isoglutamine benzyl ester hydrochloride, leading to compound 4. Removal of benzylidene and benzyl groups by successive acetic acid exposure and hydrogenolysis gave rise to 2‐acetamido‐2‐deoxy‐3‐0 (2‐D‐(^14^CO) propionyl‐L‐alanyl‐D‐isoglutamine)‐D‐glucopyranose (^14^C‐MDP) Specific activity : 42 mCi/mMole in a 10 % overall yield based on sodium (1‐^14^C) propionate.
📜 SIMILAR VOLUMES
## Abstract La synthégse du peptide immunoactif RP 56 ^14^C a été réalisée par synthése peptidique en solution à partir de L‐alanine ∥^14^C−1) d'acitvité spgcifique 52.5 mCi/mmol (1.94 GBq/mmol).
## Abstract Benzyl chloride‐7‐^14^C is condensed with 2‐lithio 2‐methyl 1,3‐dithianes. Deprotection with cupric chloride‐copper oxide of the resulting 2‐benzyl 2‐methyl 1,3‐dithianes leads to 1‐phenyl‐2‐propanone‐1‐^14^C. The latter with L(‐)α‐methylbenzylamine in presence of molecuLar sieve gives
The ^14^C labelling of three compounds : HI‐6, TMB‐4 and pyrimidoxime is described from ^14^C‐formic acid, sodium salt. The compounds were prepared by lithiation and formylation with N‐methyl (^14^C)‐formanilide followed by introduction of the hydroxylamine moieties and alkylation of the pyridine. R
The two compounds were labelled by ^14^C on the hydroxyimino methyl group substituted on the 2 positions of the pyridinium ring. The convenient pyridinium lithiated intermediates were formylated with N‐methyl ^14^C‐formanilide. The hydroxyimino methyl groups were synthezised by reaction of the ^14^